Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q3 2020 · 10-Q
Revenue$35.84M$35.84M+71.8% vs Q3 2019 Net Income-$10.39M-$10.39MN/M vs Q3 2019 EPS Diluted-$0.39-$0.39N/M vs Q3 2019 Gross Profit$30,631,000+76.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$8,909,000N/M Free Cash Flowderived-$10,124,000N/M Margins · derivedGross margin85.5%+2.0 pt vs Q3 2019
Operating margin-27.6%+13.9 pt vs Q3 2019
Net margin-29.0%+10.6 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 2, 2020 · 33 d after period end